Navigation Links
QBT Fatty Acid Uptake Assay Kit datasheet



NO RADIOACTIVITY

NO WASH STEPS

EASY SINGLE-STEP ASSAY

HTS READY


FATTY ACID UPTAKE AND TRANSPORTERS

Fatty acids are utilized for diverse cellular processes including mitochondria oxidation, membrane synthesis and energy storage. Pathologically increased intracellular fatty acid concentrations can cause cellular apoptosis and have been linked to insulin desensitization, Type 2 diabetes, obesity and cardiovascular disease. All of these intracellular processes are dependent upon fatty acids traversing the plasma membrane to get into the cell. Therefore, understanding the Fatty Acid Transport Proteins (FATP) that regulate this process is of great importance in biomedical research and drug discovery.

FATPs are part of an evolutionarily conserved family of proteins of which six FATP family members are expressed in the human genome. While all six human FATPs are similar in function, they differ dramatically in their expression in various tissue and organs. The differences in FATP expression pattern therefore make it possible to selectively target the uptake of fatty acids into specific organs by using compounds that can discriminate between the different FATP family members.


CONVENTIONAL METHODS
The development of fatty acid uptake regulators as potential drugs for metabolic diseases requires robust assays for the quantitation of fatty acid uptake. Conventional protocols utilizing radioactivity often require cell lysis and processing at very low temperature, making them expensive, slow and not suitable for high throughput screening. Fluorescence-based protocols generally require the use of low throughput Fluorescence Activated Cell Sorter (FACS) instrumentation, or require cell washing, which can severely com promise the integrity of fragile adipocyte cells.


OPTIMIZED ASSAY
The QBT Fatty Acid Uptake Assay is a single-step homogeneous fluorescent assay that provides real-time uptake kinetics and is ideally suited for high throughput screening applications in both 96-well and 384-well formats. The kit employs a BODIPY-dodecanoic acid fluorescent fatty acid analog coupled with Molecular Devices proprietary quench technology. The BODIPY label provides an ideal long chain fatty acid analog that behaves much like natural fatty acids: it becomes activated by acyl-CoA attachment; is incorporated into di-and triglycerides; and accumulates in intracellular lipid droplets. In addition, the BODIPY analog is a known substrate for fatty acid transporters since its uptake by adipocytes can be competed by non-labeled fatty acids. The elimination of radioactive compounds results in easier reagent handling, reduced disposal costs and eliminates safety risks associated with radiolabel assays.


PATENTED TECHNOLOGY
QBT Assay Kits from Molecular Devices employ a quenching dye to reduce background fluorescence and improve the signal-to-noise ratio. The patented quench technology is offered to drug discovery and life science researchers exclusively by Molecular Devices, through the purchase of QBT Assay Kits.


OBSERVE TRUE BIOLOGICAL ACTIVITY
Consistent with the observation that FATPs are only expressed by differentiated cells, 3T3 L1 adipocytes take up the BODIPY analog and accumulate it in lipid droplets. In contrast, undifferentiated 3T3L1 fibroblasts do not transport or store the dye. (See Figure 1.) Known activators and inhibitors of fatty acid uptake can be seen to stimulate or inhibit uptake in adipocytes in a dose-dependent manner, but show no effect on uptake in undifferentiated fibroblasts. (See Figures 2 and 3.)


RAPID AS SAY DEVELOPMENT
The streamlined homogeneous format makes the QBT Fatty Acid Uptake Assay Kit less labor intensive to run. With the single step mix-andread procedure, the cells can be incubated with the reagents and are stable for up to several hours. Rapid analysis of the cells can be followed with the detection on any bottom-read fluorescence plate reader, including Molecular Devices Gemini EM, SpectraMax M5, Analyst, FlexStation and FLIPR microplate readers.


ORDERING INFORMATION
QBT Fatty Acid Uptake Assay Kit (Explorer) Part Number: R8132
(10) 1-plate reagent vials
Provides sufficient reagent for 10 plates (96- or 384-well)

QBT Fatty Acid Uptake Assay Kit (Bulk) Part Number: R8133
(10) 5-plate reagent vials
Provides sufficient reagent for 50 plates (96- or 384-well)


SALES OFFICES
USA 800-635-5577
UK +44-118-944-8000
Germany +49-89-9605-880
Japan +81-3-5282-5261

Check our web site for a current listing of our worldwide distributors:
www.moleculardevices.com


Analyst, FlexStation, FLIPR and SpectraMax are registered trademarks and QBT is a trademark of Molecular Devices Corporation.

BODIPY is a registered trademark of Molecular Probes, Inc.

Quenching technology is covered under U.S. Patent 6,420,183 and EPO Patent 0 906 572.


back to top


'"/>

Source:


Page: All 1 2 3

Related biology technology :

1. A Robust LC/MS/MS Method for the Quantitation of Very Long Chain Fatty Acids for Research into the Characterization of Peroxisomal Disorders
2. A Positive Selection Assay for Mutation Analysis in Big Blue Animals
3. Luminol-enhanced Assay for Superoxide Anion (O2 face="Symbol" )
4. Organize Your Data from the Big Blue Mutation Assay
5. Fluorescence-Based Single-Tube Assays to Rapidly Detect Human Gene Mutations
6. RNase Protection Assay (RPA) Using DIG-Labeled RNA Probes
7. measuring cell proliferation with SpectraMax M5, M2 and Gemini microplate readers using the CyQUANT Cell Proliferation Assay
8. Matched siRNAs and Assays: Ambion + Applied Biosystems = RNAi Success
9. Using Validated siRNAs in Functional Genomic Assays
10. Nuclease Protection Assays: The Basics
11. RNArticles: RNA Amplification Used to Develop a New In Vitro HCMV Assay
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2016)... -- A person commits a crime, and the detective uses ... criminal down. An outbreak of foodborne illness makes ... uses DNA evidence to track down the bacteria that caused ... not. The FDA has increasingly used a complex, cutting-edge technology ... Put as simply as possible, whole genome sequencing is a ...
(Date:6/23/2016)...  The Prostate Cancer Foundation (PCF) is pleased to announce 24 ... for prostate cancer. Members of the Class of 2016 were selected from a ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... today announced the launch of the Supplyframe Design Lab . Located in ... to explore the future of how hardware projects are designed, built and brought ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
Breaking Biology Technology:
(Date:6/9/2016)... leader in attendance control systems is proud to announce the introduction of fingerprint attendance ... the right employees are actually signing in, and to even control the opening of ... ... ... Photo - ...
(Date:6/2/2016)... , June 2, 2016 The ... has awarded the 44 million US Dollar project, for ... Embossed Vehicle Plates including Personalization, Enrolment, and IT Infrastructure ... leader in the production and implementation of Identity Management Solutions. ... January, however Decatur was selected for ...
(Date:5/24/2016)... facilitates superior patient care by providing unparalleled technology to leaders of the medical imaging ... product recently added to the range of products distributed by Ampronix. Photo ... ... ... News ...
Breaking Biology News(10 mins):